Xencor Inc (NASDAQ:XNCR), watched as a high level insider greatly lower his holdings through a transaction officially filed today, August 13th. Director John S. Stafford sold 124,000 shares of common stock in the company at an average price of $9.37 per share. Following the completion of this transactions, Stafford now has 27,638 shares invested in the company directly, while having 7,581,246 shares involved indirectly.
Xencor Inc (NASDAQ:XNCR) is a $309.56 million market cap biopharmaceutical company. The Company has focused on discovering and developing engineered monoclonal antibodies to treat severe and life-threatening diseases with unmet medical needs. As well, the Company uses its XmAb technology platform to create antibody product candidates designed to treat autoimmune and allergic diseases, cancer and other conditions.
In addition, the largest hedge fund involvement comes from Ra Capital Management, the fund controlled by Peter Kolchinsky, which holds a total of 2,725,000 shares worth nearly $32 million.
Disclosure: The author, Daniel Forstein, holds no positions in any stocks mentioned.